• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

GERN:US

3.3200 USD 0.0900 2.79%

As of 20:10:00 ET on 01/26/2015.

Snapshot for Geron Corp (GERN)

Open: 3.2600 Day's Range: 3.2199 - 3.3800 Volume: 2,160,174
Previous Close: 3.2300 52wk Range: 1.3134 - 5.2345 1-Yr Rtn: -37.48%

Stock Chart for GERN

No chart data available.
  • GERN:US 3.3300
  • 1D
  • 1M
  • 1Y
3.2300
Interactive GERN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for GERN

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.2500
Est. EPS (USD) (12/2014) -0.0050
Est. PEG Ratio -
Market Cap (M USD) 521.94
Shares Outstanding (M) 157.21
30 Day Average Volume 3,173,671
Price/Book (mrq) 3.8049
Price/Sale (ttm) 402.7591
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/17/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for GERN

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for GERN

Geron Corporation is a clinical stage biopharmaceutical company developing a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies.

John A ScarlettPresident/CEOOlivia K BloomExec VP:Finance/CFO/Treasurer
Stephen N RosenfieldExec VP/General Counsel/SecyAndrew J Grethlein "Andy"Exec VP:Tech Operations
More Company Profile & Key Executives for GERN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil